AI Analysis AI Analysis of BIIB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BIIB to Watchlist?
Some Reasons Why To Add BIIB:
  • Lower volatility than the market (beta 0.20)
  • Low bankruptcy risk (Altman Z-Score: 3.39)
  • Bullish trend confirmed on both short and long timeframes
PDF

Biogen Inc. stock price ended at $195.34 on Friday, after losing 0.565%
(Updated on Jun 05, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Jun 03, 2026 Loss -0.32%

The Biogen Inc. stock price fell by -0.565% on the last day (Friday, 5th Jun 2026) from $196.45 to $195.34. During the last trading day the stock fluctuated 2.78% from a day low at $195.23 to a day high of $200.66. The price has fallen in 6 of the last 10 days but is still up by 3.1% over the past 2 weeks. Volume has increased on the last day by 135 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 854 thousand shares were bought and sold for approximately $166.84 million.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 7.15% during the next 3 months and, with a 90% probability hold a price between $194.53 and $222.92 at the end of this 3-month period.

BIIB Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Wednesday, May 13, 2026, and so far it has fallen -4.49%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. The Biogen Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $194.46 and $191.04. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for Biogen Inc. stock

Biogen Inc. finds support from accumulated volume at $194.38 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $5.43 (2.78%) between high and low. For the last week, the stock has had daily average volatility of 2.84%.

Our recommended stop-loss: $188.93 (-3.28%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 16 days ago.)

Trading Expectations (BIIB) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Biogen Inc. to open at $197.08, and during the day (based on 14 day Average True Range), to move between $192.55 and $198.13, which gives a possible trading interval of +/-$5.58 (+/-2.90%) up or down from last closing price. If Biogen Inc. takes out the full calculated possible swing range there will be an estimated 2.90% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $194.38 (0.49%) than the resistance at $197.95 (1.34%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Biogen Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Biogen Inc. stock to perform well in the short-term.

Current score: 1.448 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $197.08 ( 0.89%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BIIB Performance

Trading levels for BIIB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 202.50 3.67%
R2 200.43 2.61%
R1 199.15 1.95%
Price 195.34
S1 195.00 -0.173%
S2 193.72 -0.83%
S3 191.65 -1.89%

Accumulated Volume Support & Resistance Levels

Level Price
R3 204.53 4.70%
R2 199.36 2.06%
R1 197.95 1.34%
Price 195.34
S1 194.38 -0.491%
S2 191.37 -2.03%
S3 183.33 -6.15%

FAQ

What is the symbol for Biogen Inc. Stock and on which exchange is it traded?
The symbol for Biogen Inc. is BIIB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Biogen Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Biogen Inc. stock to perform well in the short-term.

How to buy Biogen Inc. Stock?
Biogen Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Biogen Inc. Stock.

What's the current price of Biogen Inc. Stock?
As of the end of day on the Jun 05, 2026, the price of an Biogen Inc. (BIIB) share was $195.34.

What is the 52-week high and low for Biogen Inc. Stock?
The 52-week high for Biogen Inc. Stock is $205.97 and the 52-week low is $121.06.

What is the market capitalization of Biogen Inc. Stock?
As of the Jun 05, 2026, the market capitalization of Biogen Inc. is 28.839B.

When is the next earnings date for Biogen Inc.?
The upcoming earnings date for Biogen Inc. is Jul 30, 2026.
Click to get the best stock tips daily for free!
ABOUT BIOGEN INC.
Biogen
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an ad...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE